Agilent Technologies (A) to Acquire BIOVECTRA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Jefferies Reiterates Hold Rating on Agilent (A)
July 22, 2024 12:42 PM EDTJefferies analyst Brandon Couillard reiterated a Hold rating and $135.00 price target on Agilent (NYSE: A).
The analyst comments "Agilent's move to acquire BIOVECTRA ($925M, or ~7x '24 revenues) would expand exposure to specialized CDMO market, adding PDNA, mRNA and HPAPI capabilities to... More
